2018 MRS Spring Meeting

Call for Papers

Accepting New Late Breaking Abstracts
December 1, 2017—January 11, 2018 (11:59 pm ET)


Submit an Abstract

Symposium SM06—The Future of Neuroengineering—Relevant In Vivo Technology

In the field of Neuroengineering it is very fashionable to use the term in vivo. Unfortunately, the use of this term is frequently synonymous with simple characterization techniques that demonstrate components and devices are not broken – and an animal is used in the process. This may seem to be a very pessimistic view of the field, however we believe the next "break-out" in Neuroengineering will in fact be the development of in vivo devices, with explicit medical and neuroscientific questions to answer.

The challenges around in vivo testing of novel and often polymer based technologies have been associated with producing robust devices with chronic stability. It is only with recent advances across the past 5 years that new approaches have enabled more control over polymer design and fabrication such that stable technologies have been developed. However, with these advances it is necessary to take the field into a translational stage where we move beyond the bench and into the clinic

This symposium is absolutely focused on “Relevant In Vivo Technology". Indeed, every researcher in Neuroengineering is familiar with :

a) in vitro papers about device X, ending with "we look forward to possible applications in vivo" or "this paves the way for future applications in vivo". Frequently, the proposed “in vivo” applications would require massive infrastructure and technological development making speculation on in vivo relevance tenuous at best.

b) in vivo papers with very limited testing and applicability. This is typically in anesthetized animals, with frequently smaller numbers of animals. And the purpose of the paper seems to be a demonstration of the new technology not being broken, rather than an investigation of a medical or neuroscientific application with the new technology.

A very robust set of talks focused on new technology with medically or neuroscientifically relevant applicability in vivo is necessary at this time. Interdisciplinary topics related to materials science, engineering, and neuroscience will be connected by invited abstracts in order to accelerate the development of materials and devices toward applications. The closing session will be dedicated to a comparison of related technologies to motivate discussions toward generalized materials for Neuroengineering. Finally, while the field has been driven by academic inspiration, it is now more critical to look to industry partners (see industry co-organizer) to assist with commercialization, safety, and efficacy for regulatory requirements.

Topics will include:

  • Producing sterile techniques for novel materials: from the clean room to rodents
  • Translational studies: from rodents to the clinic
  • Theory and modeling of materials for the in vivo environment
  • Biocompatibility and regulatory requirements
  • Medical vs Neuroscientific Relevance
  • A tutorial complementing this symposium is tentatively planned.

Invited Speakers:

  • Antal Berényi (University of Szeged / Amplipex, Hungary)
  • Magnus Berggren (Linköping University, Sweden)
  • Shadi Dayeh (University of Calfornia, San Diego, USA)
  • Balazs Hangya (KOKI, Hungary)
  • Dion Khodagholy (Columbia University, USA)
  • Tae-il Kim (Sungkyunkwan University, Republic of Korea)
  • George Malliaras (Ecole de MINES Saint-Étienne, France)
  • David Martin (University of Delaware, USA)
  • Sergio Martinoia (Università degli studi di Genova, Italy)
  • Damijan Miklavcic (University of Ljubljana, Slovenia)
  • Florian Mormann (Universität Bonn, Germany)
  • Rod O'Connor (École des Mines de Saint-Étienne, France)
  • Jonathon Rivnay (Northwestern University, USA)
  • Daniel T. Simon (Linköping University, Sweden)
  • Andrea Slezia (Aix-Marseille University, France)
  • Luisa Torsi (Università degli studi di Bari Aldo Moro, Italy)

Symposium Organizers

Adam Williamson
Aix-Marseille University
France
33-7-82-18-89-42, adam.williamson@univ-amu.fr

Antal Berényi
Amplipex Ltd
Hungary
36-62-545-373, amplipex@amplipex.com

Rylie Green
Imperial College London
England

Mohammad Reza Abidian
University of Houston
USA
713-743-0869, mabidian@uh.edu

Keywords for Abstract Submission

Bioelectronics, Heath Technology, Neural Implants